ProfoundBio Funding: $250M Raised, Series B (2024)
ProfoundBio is a Biotech company based in Seattle. It has raised $250M in total funding. Latest round: Series B.
ProfoundBio funding overview
ProfoundBio is a Biotech company based in Seattle. ProfoundBio has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in February 2024. The round record for ProfoundBio runs through 2024; nothing later has been disclosed. Investors on record include Ally Bridge Group, Nextech Invest, T. Rowe Price, Janus Henderson Investors, RA Capital Management, OrbiMed. 6 distinct backers are named across the disclosed rounds.
ProfoundBio at a glance
Total raised
$250M
Latest round
Series B
Latest round date
February 2024
Industry
Biotech
Headquarters
Seattle
Notable investors
Ally Bridge Group, Nextech Invest, T. Rowe Price, Janus Henderson Investors, RA Capital Management, OrbiMed
Frequently asked about ProfoundBio funding
How much has ProfoundBio raised?
ProfoundBio has raised $250M in total disclosed funding across the rounds on record.
Who has invested in ProfoundBio?
Ally Bridge Group, Nextech Invest, T. Rowe Price, Janus Henderson Investors, RA Capital Management, OrbiMed are named among the investors backing ProfoundBio.
What was the latest ProfoundBio funding round?
The most recent disclosed round is a Series B, announced in February 2024.
Where is ProfoundBio based?
ProfoundBio is based in Seattle.
What sector does ProfoundBio operate in?
ProfoundBio is tracked under Biotech from Seattle, with $250M in disclosed funding.
When did ProfoundBio last raise?
The last disclosed ProfoundBio round closed in February 2024 at Series B.
Round data for ProfoundBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.
